These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 20671520)
1. Pathogenesis of Sjögren's syndrome and therapeutic consequences. Mariette X; Gottenberg JE Curr Opin Rheumatol; 2010 Sep; 22(5):471-7. PubMed ID: 20671520 [TBL] [Abstract][Full Text] [Related]
2. Activation of the type I interferon pathway in primary Sjögren's syndrome: an update. Vakaloglou KM; Mavragani CP Curr Opin Rheumatol; 2011 Sep; 23(5):459-64. PubMed ID: 21760509 [TBL] [Abstract][Full Text] [Related]
3. B cell-targeted therapies in Sjögren's syndrome. Tobón GJ; Pers JO; Youinou P; Saraux A Autoimmun Rev; 2010 Feb; 9(4):224-8. PubMed ID: 19671451 [TBL] [Abstract][Full Text] [Related]
4. The possible etiopathogenic genes of Sjögren's syndrome. Takei M; Shiraiwa H; Azuma T; Hayashi Y; Seki N; Sawada S Autoimmun Rev; 2005 Sep; 4(7):479-84. PubMed ID: 16137615 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential for B-cell modulation in Sjögren's syndrome. Mariette X Rheum Dis Clin North Am; 2008 Nov; 34(4):1025-33, x. PubMed ID: 18984420 [TBL] [Abstract][Full Text] [Related]
6. New advances in the classification, pathogenesis and treatment of Sjogren's syndrome. Mavragani CP; Nezos A; Moutsopoulos HM Curr Opin Rheumatol; 2013 Sep; 25(5):623-9. PubMed ID: 23846338 [TBL] [Abstract][Full Text] [Related]
7. Sjögren's syndrome after infection by Epstein-Barr virus. Gaston JS; Rowe M; Bacon P J Rheumatol; 1990 Apr; 17(4):558-61. PubMed ID: 2161461 [TBL] [Abstract][Full Text] [Related]
8. Type I interferons in Sjögren's syndrome. Yao Y; Liu Z; Jallal B; Shen N; Rönnblom L Autoimmun Rev; 2013 Mar; 12(5):558-66. PubMed ID: 23201923 [TBL] [Abstract][Full Text] [Related]
9. Potential role of Epstein-Barr virus in Sjögren's syndrome. Fox RI; Chilton T; Scott S; Benton L; Howell FV; Vaughan JH Rheum Dis Clin North Am; 1987 Aug; 13(2):275-92. PubMed ID: 2827246 [TBL] [Abstract][Full Text] [Related]
10. [B lymphocytes in Sjögren's syndrome]. Pers JO; Le Pottier L; Devauchelle V; Saraux A; Youinou P Rev Med Interne; 2008 Dec; 29(12):1000-6. PubMed ID: 18403061 [TBL] [Abstract][Full Text] [Related]
11. Sjögren's syndrome: mechanisms of pathogenesis involve interaction of immune and neurosecretory systems. Fox RI; Stern M Scand J Rheumatol Suppl; 2002; 116():3-13. PubMed ID: 12109541 [TBL] [Abstract][Full Text] [Related]
12. Autoimmune diseases and Sjogren's syndrome: an autoimmune exocrinopathy. Fox PC Ann N Y Acad Sci; 2007 Mar; 1098():15-21. PubMed ID: 17332090 [TBL] [Abstract][Full Text] [Related]
13. New concepts in the pathogenesis of Sjögren's syndrome. Delaleu N; Jonsson MV; Appel S; Jonsson R Rheum Dis Clin North Am; 2008 Nov; 34(4):833-45, vii. PubMed ID: 18984407 [TBL] [Abstract][Full Text] [Related]
14. Gene expression profile in the salivary glands of primary Sjögren's syndrome patients before and after treatment with rituximab. Devauchelle-Pensec V; Cagnard N; Pers JO; Youinou P; Saraux A; Chiocchia G Arthritis Rheum; 2010 Aug; 62(8):2262-71. PubMed ID: 20506202 [TBL] [Abstract][Full Text] [Related]
15. [Effect of EB virus on the pathogenesis of primary Sjogren's syndrome]. Yang JL Zhonghua Yi Xue Za Zhi; 1989 Dec; 69(12):707-8. PubMed ID: 2560944 [No Abstract] [Full Text] [Related]